Ethmoid mucocele, a condition that usually affects adults, can be found in both children and infants with cysticfibrosis. We have caredfor two patients with cystic fibrosis and ethmoid mucoceles. Because we couldfind no references to the prognosis or any long-term follow-up data for this disorder, we contacted the physicians and families of six of the seven patients with this condition previously reported in the English literature to determine how they were managed surgically and the incidence of recurrence. Regardless of the mode of therapy. none of the mucoceles recurred.
Introduction
Mucoceles arc mucous-secreting cysts lined with respiratory epithelium which can occur in the paranasal sĩ nuses. They are benign but can cause bony destruction and subsequent local, orbital or intracranial complications. I Mucoceles are uncommon in adults and so rare in the pediatric population that their presence warrants investigation to rule out etiologic entities such as cystic fibrosis.
Cystic fibrosis (CF) is an autosomal-recessive disorder with variable penetrance, affecting exocrine glands. Cystic fibrosis affects between I in 2,000 and I in 4,500 ' Histopathologically, exocrine glands affected by cystic fibrosis demonstrate thick mucoid secretions with ductal obstruction. Elevated sweat chloride levels are identified on the diagnostic sweat test. Otolaryngologic manifestations include chronic sinusitis and nasal polyposis.' The incidence of nasal polyposis in CF has been reported as 8% to 48% in the literature.' Interestingly, the incidence of otitis media in CF is not increased as compared to the general population.
Recently, the etiology of cystic fibrosis has been linked to mutations in the cystic fibrosis transmembrane conductance regulator (CFTR) gene located on chromosome seven.' This gene encodes for a transmembrane regulator protein which appears to act as a chloride channel. The most commonly observed mutation of the CFTR gene is a deletion of three base pairs which code for one amino acid, phenylalanine, at position 508 ( F508).
In the literature, most mucoceles in the pediatric population have been found in patients with allergies or cystic fibrosis. Trauma, allergy, or an unknown mucosal defect in cystic fibrosis has been postulated to cause obstruction of the sinus ostia, but the mechanism is really unknown.
While investigating optimal therapy for two patients with cystic fibrosis with ethmoid mucoceles, we could not Patient A was a two-and-a-half-year-old girl with cystic fibrosis who came to the Temple Pediatric Otolaryngology service with an eight-month history ofright telecanthus and recurrent right dacryocystitis. Examination of the nasal cavity demonstrated extensive polyposis bilaterally with mucopurulent secretions along the nasal floor. The right eye was laterally displaced. There was no proptosis and extraocular movements were not restricted. A bulge was noted on the right nasal dorsum.
A computed tomogram (CT) of the paranasal sinuses and orbits demonstrated homogenous, nonenhancing bilateral ethmoid and maxillary sinus soft tissue densities. A cystic mass was noted emanating from the right ethmoid and displaced the right medial orbital wall laterally and superiorly. The bony walls of the ethmoid sinus were bowed outward and there was erosion of the septations within the ethmoid labyrinth. The nasal cavity was filled with a soft tissue density similar to that within the ethmoid sinus ( Figure I) .
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Patient A has been followed by both the otolaryngology and ophthalmology services for four years without evidence of recurrence of the mucocele. The patient's telecanthus has resolved and her vision remains unchanged. She underwent subsequent endoscopic sinus surgery two years following her original ethmoidectomy for recurrent polyps but no mucocele was encountered.
Case 2
Patient B is an eight-year-old boy with cystic fibrosis and a long history of partial nasal obstruction due to nasal polyposis which was managed conservatively with intranasal steroids. This progressed to complete nasal obstruction. He also complained of persistent frontal headaches and right eye pain. Physical examination revealed expansion of the nasal bridge and nasal polyps completely obstructing both nasal cavities. There was no evidence of orbital involvement.
Axial CT demonstrated soft tissue densities occupying bilateral ethmoid, maxillary and sphenoid sinuses. There was significant outward bowing of the right anterior ethmoid cells with loss of bony septae and elevation of the right ethmoid roof (Figure 2) .
Bilateral endoscopic complete ethmoidectomy, polypectomy and antrostomies were performed. Upon entering the right anterior ethmoid labyrinth thick green pus was encountered within the mucocele. There was also evidence of destruction of bony septations within the eth-Danplex has been developing and producing high quality, innovative audiological equipment for 25 years. Continually improving its products in association with medical and audiological experts in many countries. moid labyrinth. Histopath ologic exa mi natio n of the mucoce le wa ll and nasal pol yps dem on strated ma rked acut e and ch roni c infl ammation with mark edl y dilated glands filled with mu cinous materi al with or without neutrophil s.
On e year following surg ery there is no evidence of recurrent mu cocele formati on. His nasal sy mpto ms , headac hes and eye pain hav e resol ved . He is currently on intranasa l steroids to help del ay recurrent polyp formation .
Survey
Th e investigators and/or fami lies of all previously rep orted children with ethmoid mucoceles and CF wer e surveyed. Telephone inter view s addres sed the age and clinical presentation of the pati ents as well as the method of mucocele decompression and duration of follow-up. Our interviews also covered survival, need for repeat polypectomy and incidence of recurren ce of mucoceles in the se pat ient s.
Results
We were able to co ntac t the fami Iies or physicians ofsi x of the seven pedi atri c pati ent s with ethmoid mucoceles report ed in the literature. Th e result s of our interviews are summarized in Table I. Moll er and Thomsen " reported two nine-year-old patients who underwent later al rhinotom y for decompression o f ethmoid mucoceles. Both patients pre sented with painl ess orbital swe lli ng, and o ne had stra bismus. Neither had recurrenc e o f the ir muco cele s but the child with strabis mus has had recurrence of nasal polypo sis and chronic sinusi tis during a J6-ycar follow-up period. Th e secon d patient had no recurrence of nasal polyps, but died three years later from pulmonary co mplica tio ns of CF.
Robertson and Henderson in 1969 7 presented a 16month-old child with unilater al proptosis and telecanthus in whom a mucopyocel e w as found on external ethmoidectomy and inferior orbital approach exploration. Th is patient was last see n at age 21 ye ars and, although she has neede d subseque nt intran asal pol ype ct om ies, the mucocele has not recu rred.
Tw o pat ients were reported in 1966 by Stool et aI. H Both of these patients had exophthalmos, but one had epiphora and the other had orbital pain without loss of vision or extrao cular motility. The first patient was treated with intranasal decompression and had no evidence of recurrence until his death 20 years late r. The second patient In the pediatric pat ient with signs and symptoms suggestive of a mucocele it is important to rule out other entities which may have a similar presentation. The differential diagnosis of ethmoid sinu s mucoceles in the pediatric population includes meningocele, rhabdomyosarcoma, hemangioma and neuroblastoma. Bony lesions, such as fibrous dysplasia and osteomas, have also led to the formation of mucoceles by obstructing sinus ostia.
Confirmation of the diagnosis of a mucocele rests with the histopathology. The usual histologic features seen in non-CF-associated mucoceles include flattening of the pseudostratified columnar epithelium with preservation of goblet cells, and other area s with hyperplasia and metaplasia." The lining of the mucocele is composed of the mucoperiosteum of the sinus, and its stroma and basement membrane are thickened, fibrotic, and show a decrease in the number of mucou s glands. Eosinophilia and inflammatory cells are found in patients with nasal polyposis. The surrounding bone shows osteoclastic and osteoblastic activity. In contrast, the basement membrane in the nasal polyps of CF patients is often normal in thickness, and goblet cells and mucous glands are consistently dilated, containing inspissated mucous and mucoid metaplasia of the serous cells.P:"
Our review of the literature identified 27 cases of pediatric mucoceles.2.4.6-1 1J.15-17 Of these, seven (26%) patients also had CF. Symptomatic mucoceles are rare in children, possibly because they tend to be slow-growing entities. Given their increased incidence in cystic fibrosis, this disease must be considered whenever a pediatric mucocele is found. The cause of mucoceles, and especially those in CF, is not known . The defect of exocrine cell function in patients with CF may contribute to a different etiology for mucoceles in this population since the incidence of allergy in patient s with CF is about the same as in normal populations.
It is interesting to note the lack of recurrences of mucoceles regardless of the mode of surgical management. Seventy-one percent of the patients wi th mucoceles underwent an external ethmoid or lateral approach, while 29% simply had intranasal drainage. Se- 
Recurrent nasal polyposis
Follow-up
Discussion
Ethmoid sinus mucoceles often appear with painless orb ital swelling. Other associated symptoms include diplopia, chemosis, epiphora and nasal obstruction. Ifinfected, sinusitis and/or orbital cellulitis with erythema, fever and pain can occur in the involved area. Deep-seated pain and epistaxi s are rare and may indic ate malignancy. As the mucocele enlarges, the orbital contents may become displaced, resulting in diplopia, proptosis and limitation of extraocular mobility. Rarely, intracranial extension can occur, leading to meningitis or cerebrospinal fluid leakage.
Diagnosis ofethmoid sinus mucoceles is often made by CT which demonstrates bony erosion of the sinus wall with smooth outward displacement. Magnetic resonance imaging (MRI) of mucoceles will show variable signal intensity in both the TI-and T2-weighted image. 10 The signal intensity of the Tl-weighted image is based on the viscosity and protein concentration of the mucocele while the T2 signal intensities are inversely proportional to the degree of dehydration. I I The disadvantage of MRI compared to CT is its lack ofbony detail, and it is therefore not as useful in preoperative assessment. Plain roentgeno-underwent a lateral rhinotomy approach for his ethmoid mucocele and survives today with chronic sinusitis and no evidence of recurrence.
The six-year-old patient reported by Guttenplan and Wetmore in 1989 9 had been followed for three years after she developed epiphora. Since undergoing an intranasal drainage procedure she has had no recurrence of the mucocele. We were not able to locate Drs. Mendelson and Cohen, but their paper reports a three-year follow-up of a patient who presented with proptosis and astigmatism. The mucocele was drained by external ethmoidectomy and did not recur during this three-year period.' lection of these approaches was based primarily on the extent of orbital involvement and the need for access to the orbit. There were no reports of permanent deficits or complications following the decompression of ethmoid mucoceles. Although the mucoceles did not recur, these patients continued to suffer from chronic sinusitis and recurrent polyposis. This lack of recurrence of mucoceles could reflect the efficacy of proper intranasal drainage or the early mortality of patients with CF and lack of longterm follow-up. However, one of Stool's patients discussed above had no recurrence during 20 years offollowup after intranasal drainage," suggesting that this therapeutic approach may have long-term success in at least some cases.
Summary
Pediatric patients with proptosis and/or telecanthus should have a thorough head and neck work-up for ophthalmologic, nasal and paranasal sinus disease. A CT scan should be obta ined for further evaluation of the extent of the disease. IfCT findings are consistent with a mucocele.
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External and intranasal approaches to surgical drainage are described. Our experience with endoscopic sinus surgery in children with mucoceles has been favorable. The endoscopic endonasal approach appears to be safe in experienced hands. Classic external ethmoidectomy is recommended in very small children or when intracranial extension is likely.
The long-term prognosis for children with mucoceles is good, with orbital signs and symptoms generally resolving after drainage procedures. With long-term follow-up, no recurrences of mucoceles have been reported in pediatric patients with cystic fibrosis but, in our review, 29% of these patients have continued to suffer from chronic sinusitis and 43% have had recurrent nasal polyposis. As treatment of CF improves and the patients survive into adulthood. longer follow-up data will become available.
